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Cover image: Lab Resources articles in Stem Cell Research were launched in June 2015 to provide a peer reviewed catalogue of ethically 
derived and genetically characterised pluripotent stem cell lines. In this issue we are celebrating the success of this initiative with the 100th 
published Lab Resource article. The cover depicts the two main sources of human pluripotent stem cells, induced pluripotent stem cells from 
reprogramming and embryonic stem cells from pre-implantation embryos. Further, methods of validation of pluripotent lines are shown: 
PluriTest, immunofluorescence for the pluripotent marker SSEA4 and karyotypic analysis. Cover art by: Mattias Karlen.
